The Prognostic Implications of Change in LVEDP during TAVI
Patients in whom LVEDP increases post-TAVI have a significantly higher incidence of mortality and HFH within 1 month, and this persists for at least 5-years post-procedure. According to our results, the change in LVEDP is a more powerful predictor of adverse clinical outcomes than elevated post-TAVI LVEDP alone.
Authors
- Paul Bamford (ORCID: https://orcid.org/0000-0001-5533-3919)
- Rowan Hall
- Nadir Elamin
- Christopher J. Malkin (ORCID: https://orcid.org/0000-0002-6643-6830)
- Amanda Sherwen
- Kate Gatenby
- Amr Abdelrahman (ORCID: https://orcid.org/0000-0002-0149-9400)
- Amir Aziz
- Daniel J. Blackman (ORCID: https://orcid.org/0000-0001-9039-6130)
- Suleman Aktaa (ORCID: https://orcid.org/0000-0002-9854-481X)
- Noman Ali (ORCID: https://orcid.org/0000-0002-9597-4451)
- Michael S. Cunnington
Institutions
- Leeds General Infirmary (GB)
- Northern General Hospital (GB)
- University of Newcastle Australia (AU)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1002/ccd.31508
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00